PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Keng‐Hsueh Lan et al.|Cancer Cell|2004Cited by 1.9k
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activityChia‐Wei Li, Mien‐Chie Hung|Nature Communications|2016Cited by 1.1k
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasionJung-Mao Hsu, Mien‐Chie Hung|Nature Communications|2018Cited by 427
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasionLi-Chuan Chan, Mien‐Chie Hung|Journal of Clinical Investigation|2019Cited by 380
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Mien‐Chie Hung|Journal of Clinical Investigation|2021Cited by 311